$53.30 -0.58 (-1.08%)
11/27/2009 1:00 PM

Covance, Inc. (CVD)

CAPS Rating: 4 out of 5

A drug development services company providing a range of early stage and late stage product development services on a worldwide basis primarily to the pharmaceutical, biotechnology and medical device industries.

Results 1 - 1 of 1

Recs

2
Member Avatar epumple (< 20) Submitted: 6/26/2008 2:44:25 PM : Underperform Start Price: $82.89 CVD Score: +21.24

Covance is notorious for its cruel treatment of its laboratory animals and is the subject
of a major campaign by Peta. Unlike most industries that use animals, Covance has
been totally resistant to negotiation on this issue. I believe this is a sign of unethical
management and expect this company to do poorly.

Report this Post 5 Comments | Reply | Permalink
Results 1 - 1 of 1

Featured Broker Partners